BPBIO750— 510(k) K231174

Substantially Equivalent

Inbody Co., Ltd.

FDA 510(k) clearance K231174 for BPBIO750, Substantially Equivalent on 2023-08-02. Applicant: Inbody Co., Ltd..

Clearance details

Applicant: Inbody Co., Ltd.
Product code: Code DXN
Advisory panel: Cardiovascular
Date received: 2023-04-25
Decision date: 2023-08-02
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Cheonan-Si, KR

Download summary PDF View on FDA.gov ↗

Adverse events under product code DXN

product code DXN

Death: 3
Injury: 169
Malfunction: 1,019
Other: 2
Total: 1,193

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.